Giving Tuesday

Become a Member of UsAgainstAlzheimer’s this Giving Tuesday and DOUBLE YOUR IMPACT in the fight to stop Alzheimer’s. Nothing we do would be possible without the support of compassionate donors and advocates like you. That is why we hope you will support us on Giving Tuesday and make a gift today.

This November, we’re honoring Alzheimer’s Awareness Month.

Understand your brain health today — and take the first step with BrainGuide.

UsAgainstAlzheimer’s Applauds Senate Appropriators for Robust Investments in Alzheimer’s Programs

These significant investments in research underscore the millions of Americans impacted by Alzheimer’s and other dementias.

UsAgainstAlzheimer’s Launches Clinical Trial Connector to Improve Access to Alzheimer’s Research

UsAgainstAlzheimer's announced the launch of the BrainGuide Clinical Trial Connector, a free, confidential tool developed in partnership with Carebox. This new resource helps individuals, caregivers, and healthcare providers easily find and connect with clinical trials for Alzheimer’s disease and related dementias (ADRD).

Join the UsAgainstAlzheimer's Membership Program

Become a Member of UsAgainstAlzheimer's today and join a movement of people who don’t just talk about the Alzheimer’s crisis, but become part of the solution.

Giving Tuesday

Early detection can change lives.

UsAgainstAlzheimer’s Applauds Robust Investments in Alzheimer’s Programs

UsAgainstAlzheimer’s Launches Clinical Trial Connector to Improve Access to Alzheimer’s Research

Become a Member

VISION: UsAgainstAlzheimer's envisions a world without Alzheimer's where brainspan equals lifespan. 

MISSION: Catalyze change in the health ecosystem to improve dementia prevention, early detection, and access to treatments through advocacy, policy, convening, and high-leveraged programs, with a particular focus on health equity.   

 

Prevention

Alzheimer’s is not a normal part of aging. There are things we can all do to reduce our risk, like eating a healthy diet, exercising, and getting good sleep. People need to know what’s good for the body is good for the brain. Learn more about our prevention work and how you can take charge of your brain health.

CLICK HERE FOR MORE INFO

Early Detection & Diagnosis

Early detection and diagnosis give people a better chance of managing the disease. On top of that, current treatments are most effective with patients in the early stages of dementia.

Find out how we are raising awareness of the importance of early detection and how BrainGuide is helping people concerned about their brain health start a conversation with their doctor.

CLICK HERE FOR MORE INFO

Access to Treatments

We are working on multiple fronts to get safe and effective treatments into the hands of people who need them most. That includes working to ensure Alzheimer’s patients are treated fairly as the federal government considers drug approval and Medicare coverage for treatments.

See how else UsAgainstAlzheimer’s is fighting for access to treatments.

CLICK HERE FOR MORE INFO

 

Center for Brain Health Equity

Most Alzheimer’s patients are women, Latinos, and Black people. As a patient-centered organization, all our work is done with equity in mind, so we are addressing needs of the people who are most heavily impacted by the disease. Learn more about how UsAgainstAlzheimer’s Center for Brain Health Equity is working toward a healthcare system that works for everyone.

Recent News and Blog Posts

  • November 22, 2024

    Senate Passes BOLD Act to Strengthen Alzheimer's Public Health Response

    UsAgainstAlzheimer’s chair and co-founder, George Vradenburg, issued the following statement in response...

    Read more
  • November 14, 2024

    UsAgainstAlzheimer’s Statement on Alzheimer’s Treatment Approval in the European Union

    UsAgainstAlzheimer’s applauds the Committee for Medicinal Products for Human Use (CHMP) of...

    Read more
  • Centers for Medicare and Medicaid Services: Appropriately cover the costs of blood tests helping to detect Alzheimer’s

    UsAgainstAlzheimer’s, along with a coalition of leading advocacy groups, is calling for...

    Read more
  • October 23, 2024

    Members of Congress Call for More Action on Alzheimer’s

    Read more
  • October 10, 2024

    New Poll: Bipartisan Majority Believes Medicare Beneficiaries Should Have Access to FDA-approved Early Alzheimer’s Medications the Same Way They Do for All Other Diseases

    American voters are willing to pay more to ensure access and want...

    Read more
  • October 02, 2024

    President Signs NAPA Reauthorization and AAIA into Law—A Major Victory in the Fight Against Alzheimer’s

    Read more

Reports

  • Resources
    report

    2024 Annual Report

  • Resources
    2023 report

    2023 Annual Report

  • Resources

    2022 Annual Report